表 1.

各型FD患者的临床及随访资料

Clinical characteristics and follow-up data of the different types of FD patients

Items	MFD (n=43)	PFD (n=32)	MAS (n=7)	CFD (n=23)	Total (n=105)
Data are presented as x±s, n (%), or M (P25, P75). FD, fibrous dysplasia; MFD, monostotic fibrous dysplasia; PFD, polyostotic fibrous dysplasia; MAS, McCune-Albright syndrome; CFD, craniofacial fibrous dysplasia; ALP, alkaline phosphatase; NA, not available.
Onset age/years	15.00 (13.00, 30.00)	9.50 (5.50, 12.75)	8.57±2.37	10.00 (6.00, 14.00)	12.00 (8.00, 17.00)
Onset age group/years
≤10	7 (16.28)	21 (65.63)	5 (71.43)	13 (56.52)	46 (43.81)
11-20	23 (53.49)	7 (21.88)	2 (28.57)	7 (30.43)	39 (37.14)
21-30	4 (9.30)	2 (6.25)	0 (0)	2 (8.70)	8 (7.62)
31-40	6 (13.95)	1 (3.13)	0 (0)	1 (4.35)	8 (7.62)
41-50	1 (2.32)	1 (3.13)	0 (0)	0 (0)	2 (1.90)
51-60	2 (4.65)	0 (0)	0 (0)	0 (0)	2 (1.90)
Gender
Male	20 (46.51)	12 (37.50)	1 (14.29)	13 (56.52)	46 (43.81)
Female	23 (53.49)	20 (62.50)	6 (85.71)	10 (43.48)	59 (56.19)
Clinical sign
Facial deformity	39 (90.70)	32 (100.00)	7 (100.00)	23 (100.00)	101 (96.19)
Pain	8 (18.60)	2 (6.25)	1 (14.29)	1 (4.35)	12 (11.43)
Treatment
Conservative surgery	41 (95.35)	30 (93.75)	6 (85.71)	21 (91.30)	98 (93.33)
Radical surgery with reconstruction	2 (4.65)	2 (6.25)	1 (14.29)	2 (8.70)	7 (6.67)
Number of conservative operations	1.0 (1.0, 1.5)	2.0 (1.0, 3.0)	2.0 (1.0, 3.5)	1.0 (1.0, 1.5)	1.0 (1.0, 2.0)
Course	8.78±7.86	17.09±10.27	18.86±9.56	10.39±6.77	12.34±9.34
Serum ALP concentration
Elevation	5 (11.63)	22 (68.75)	6 (85.71)	11 (47.83)	44 (41.90)
Non-elevation	36 (83.72)	10 (31.25)	1 (14.29)	11 (47.83)	58 (55.24)
NA	2 (4.65)	0 (0)	0 (0)	1 (4.35)	3 (2.86)
Follow-up
No regrowth	28 (65.12)	18 (56.25)	3 (42.86)	16 (69.57)	65 (61.90)
Slow regrowth	3 (6.98)	3 (9.38)	1 (14.29)	1 (4.35)	8 (7.62)
Marked regrowth	2 (4.65)	3 (9.38)	0 (0)	2 (8.70)	7 (6.67)
Death	0 (0)	0 (0)	1 (14.29)	0 (0)	1 (0.95)
Loss to follow-up	10 (23.26)	8 (25.00)	2 (28.57)	4 (17.39)	24 (22.86)